Norris Medicines Ltd share price logo

Norris Medicines Ltd

14.30

+0.79

(+5.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Norris Medicines Stock Performance

as on June 12, 2026 at 9:31 pm IST

  • Day's Low

    ₹13.00
    ₹14.30
    downward going graph

    9.09%

    Downside

  • 52 Week's Low

    52 Week's High

    ₹12.00
    ₹19.90
    downward going graph

    16.08%

    Downside

    39.16%

    Upside

    downward going graph

Norris Medicines share price movements today

Previous Close
₹13.51
Open
₹13.50
Volume
1,704.00
Upper Circuit
₹14.86
Lower Circuit
₹12.16
Day's Low - High
₹13.00 - ₹14.30
52 Week Low - High
₹12.00 - ₹19.90

Norris Medicines Historical Returns

1 Month Return
+ 0.79 %
3 Month Return
+ 2.62 %
1 Year Return
-25.42 %
3 Year Return
+ 17.58 %
5 Year Return
+ 84.44 %

Norris Medicines Fundamentals

as on June 12, 2026 at 4:01 pm IST

Market Cap

₹21.79 Cr

Return on Equity (ROE)

11.92

PE Ratio (TTM)

0

Return on capital employed (ROCE)

17.64

Beta (LTM)

0.92

P/B Ratio

2.65

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-121.74

EPS (TTM)

2.98

Book Value

0

Norris Medicines Technical Analysis

Track how Norris Medicines technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish11
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.21
Bullish
CCI (20)
55.33
Neutral
RSI (14)
70.68
Bearish
Momentum (10)
0
Neutral
ADI (14)
54.24
Neutral
Ultimate Oscillator (7,14,28)
93.3
Bullish

Moving Averages

Name

Value

Action

SMA (20)
13.97
Bullish
EMA (20)
14.07
Bullish
VWMA (20)
14.18
Bullish
SMA (50)
13.69
Bullish
EMA (50)
13.81
Bullish
SMA (200)
13.55
Bullish
EMA (200)
13.61
Bullish
KAMA (200)
13.97
Bullish
DEMA (200)
13.63
Bullish

Norris Medicines Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Norris Medicines with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA21.79-3.72%0.69271
BUY19,463.1619.61%0.763742,908
NA93.001.65%0.00375
NA4,220.22185.19%0.0048150
NA220.7415.92%0.004473

Norris Medicines Stock’s Investor Sentiment and Interest

Search interest for Norris Medicines Ltd Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

Norris Medicines Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
0.95
2.56
0.65
1.49
0.72
1.27
1.11
2.72
1.46
2
3.27
1.41
Other Income
-
-
-
0.03
0.01
-
-
0.05
0.02
-
-
0.02
Total Income
0.95
2.56
0.65
1.52
0.74
1.27
1.11
2.77
1.48
2
3.27
1.43
Expenses
1.33
2.8
0.69
1
0.89
1.41
1.13
2.65
1.56
2.49
2.32
1.1
Operating Profit
-0.38
-0.24
-0.04
0.49
-0.17
-0.14
-0.02
0.07
-0.1
-0.49
0.95
0.31
Operating Profit Margin %
-40%
-9.37%
-6.15%
32.89%
-23.61%
-11.02%
-1.8%
2.57%
-6.85%
-24.5%
29.05%
21.99%
Profit Before Interest, Tax and Depreciation
-0.39
-0.25
-0.04
0.51
-0.15
-0.14
-0.02
0.12
-0.08
-0.49
0.95
0.33
Interest
0.09
0.09
0.09
0.11
0.08
0.08
0.12
0.15
0.11
0.11
0.13
0.15
Depreciation
0.14
0.14
0.14
0.14
0.13
0.13
0.13
0.14
0.12
0.12
0.12
0.12
Profit Before Tax
-0.62
-0.48
-0.27
0.26
-0.36
-0.35
-0.27
-0.17
-0.31
-0.72
0.7
0.06
Tax Paid
-
-
-
0.09
-
-
-
0.06
-
-
-
-
Profit After Tax
-0.61
-0.48
-0.27
0.17
-0.37
-0.36
-0.28
-0.23
-0.31
-0.72
0.7
0.05
Total Net profit including share of profit / Loss from associate company
-0.61
-0.48
-0.27
0.17
-0.37
-0.36
-0.28
-0.23
-0.31
-0.72
0.7
0.05
EPS
-0.61
-0.48
-0.27
0.17
-0.37
-0.36
-0.28
-0.23
-0.31
-0.72
0.7
0.05
Actual EPS
-0.61
-0.48
-0.27
0.17
-0.37
-0.36
-0.28
-0.23
-0.31
-0.72
0.7
0.05
Adjusted EPS
-0.61
-0.48
-0.27
0.17
-0.37
-0.36
-0.28
-0.23
-0.31
-0.72
0.7
0.05
Diluted EPS
-0.61
-0.48
-0.27
0.17
-0.37
-0.36
-0.28
-0.23
-0.31
-0.72
0.7
0.05

Norris Medicines Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
13.57
16.27
7.84
12.25
9.44
8.36
5.64
5.82
8.13
Other Income
-
-
0.09
0.05
0.03
0.01
0.03
0.06
0.05
Total Income
13.71
16.31
7.93
12.3
9.46
8.37
5.66
5.88
8.18
Expenses
15.49
16.88
10
13.99
9.51
7.44
5.82
6.08
7.47
Operating Profit
-1.92
-0.61
-2.16
-1.74
-0.07
0.92
-0.18
-0.26
0.66
Operating Profit Margin %
-14.15%
-3.75%
-27.55%
-14.2%
-0.74%
11%
-3.19%
-4.47%
8.12%
Profit Before Interest, Tax and Depreciation
-1.78
-0.57
-2.07
-1.69
-0.05
0.94
-0.16
-0.2
0.71
Interest
0.7
0.73
0.88
1.63
1.48
1.5
0.37
0.44
0.5
Depreciation
0.71
0.71
0.73
0.67
0.66
0.63
0.57
0.54
0.49
Profit Before Tax
-3.19
-2.01
-3.68
-3.99
-2.19
-1.19
-1.1
-1.18
-0.28
Tax Paid
-0.67
-0.33
-0.84
0.97
1.08
0.56
0.09
0.06
-
Profit After Tax
-2.51
-1.68
-2.84
-4.96
-3.26
-1.75
-1.19
-1.24
-0.28
Total Net profit including share of profit / Loss from associate company
-2.51
-1.68
-2.84
-4.96
-3.26
-1.75
-1.19
-1.24
-0.28
EPS
-2.61
-1.68
-2.84
-4.96
-3.26
-1.75
-1.19
-1.24
-0.28
Actual EPS
-2.61
-1.68
-2.84
-4.96
-3.26
-1.75
-1.19
-1.24
-0.28
Adjusted EPS
-2.61
-1.68
-2.84
-4.96
-3.26
-1.75
-1.19
-1.24
-0.28
Diluted EPS
-2.61
-1.68
-2.84
-4.96
-3.26
-1.75
-1.19
-1.24
-0.28

Norris Medicines Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1.35
-0.96
0.8
-1.92
-2.88
1.11
-1.01
1.2
0.17
0.51
Cash Flow from Investing Activities
-0.33
-2.05
-0.08
-0.28
0.01
-0.07
-0.1
-0.02
0.05
-
Cash Flow from Financing Activities
-1.32
3.16
-0.66
2.18
2.86
-1.09
1.1
-1.18
-0.2
-0.5
Net Cash Flow
-0.31
0.15
0.06
-0.02
-0.02
-0.04
-
-
0.02
-

Norris Medicines Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
34.01%
34.01%
34.01%
34.01%
34.01%
34%
34%
34%
34%
34%
34.01%
DII
0.07%
0.07%
0.07%
0.07%
0.07%
0.07%
0.07%
0.07%
0.07%
0.07%
0.07%
Public
65.92%
65.92%
65.92%
65.92%
65.92%
65.93%
65.93%
65.93%
65.93%
65.93%
65.92%
Total Outstanding Shares
1,00,00,700
1,00,00,700
1,00,00,700
1,00,00,700
1,00,00,700
1,00,00,700
1,00,00,700
1,00,00,700
1,00,00,700
1,00,00,700
1,00,00,700
Total Shareholders
25,242
25,317
25,517
25,400
25,498
25,659
25,815
25,950
25,895
25,791
25,777

Norris Medicines Corporate Actions

View detailed summary of the earnings and dividend history of Norris Medicines.

  • Norris Medicines Ltd Earnings Results

    Norris Medicines Ltd’s net profit jumped 121.74% since last year same period to ₹0.05Cr in the Q4 2025-2026. On a quarterly growth basis, Norris Medicines Ltd has generated -92.86% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Norris Medicines Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 34.00% to 34.01% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Norris Medicines stock has moved up by 6.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.5% return, outperforming this stock by 65.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 149.6% return, outperforming this stock by 132.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 65.93% to 65.92% in Mar 2026 quarter

About Norris Medicines Ltd

Norris Medicines is a pharmaceutical formulations-based company incorporated on 7 September 1990 as a private limited company. It became a public limited company in March 1992 and started commercial production of the formulation unit in November 1991. To expand its existing capacity for tablets, capsules, etc. and diversify into bulk drugs, the company came out with a public issue of Rs 5 crores in December 1993. The project, amounting to Rs. 14.21 crores, was delayed by nine months and was completed in 1995. They undertake job work/loan license work of reputed pharmaceuticals majors and are looking forward to a significant boost in exports in the upcoming years with PHC group's focus and marketing strength around the world.

Revenue: ₹1.41Cr as on March 2026 (Q4 FY26)
Net Profit: ₹0.05Cr as on March 2026 (Q4 FY26)
OrganisationNorris Medicines Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Norris Medicines share price today?

Norris Medicines share price today stands at ₹14.3 as on at the close of the market. Norris Medicines share today touched a day high of ₹14.3 and a low of ₹13.

What is the 52 week high and 52 week low range for Norris Medicines share?

Norris Medicines touched a 52 week high of ₹19.9 and a 52 week low of ₹12. Norris Medicines share price today i.e. is closed at ₹14.3, which is -28.14% down from its 52 week high and 19.17% up from its 52 week low.

What is Norris Medicines's market capitalisation today?

Norris Medicines market capitalisation is ₹14.11 Cr as on .

How to buy Norris Medicines shares?

To buy Norris Medicines shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524414 or Norris Medicines Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Norris Medicines shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Norris Medicines trading volume today?

Norris Medicines trading volume is 1,704.00 as on . This means that 1,704.00 shares of Norris Medicines were bought and sold on the stock market during today's trading session.